AAAAAA
Results:
1-13
|
Results: 13
Authors:
Tschan, MP
Vonlanthen, S
Cajot, JF
Peters, UR
Oppliger, E
Betticher, DC
Yarbrough, WG
Fey, MF
Tobler, A
Citation: Mp. Tschan et al., Different p16(INK4a) and p14(ARF) expression patterns in acute myeloid leukaemia and normal blood leukocytes, LEUK LYMPH, 42(5), 2001, pp. 1077
Authors:
Gugger, M
Kappeler, A
Vonlanthen, S
Altermatt, HJ
Ris, HB
Lardinois, D
Borner, MM
Heighway, J
Betticher, DC
Citation: M. Gugger et al., Alterations of cell cycle regulators are less frequent in advanced non-small cell lung cancer than in resectable tumours, LUNG CANC, 33(2-3), 2001, pp. 229-239
Authors:
Strasser, F
Betticher, DC
Suter, TM
Citation: F. Strasser et al., Trastuzumab and breast cancer., N ENG J MED, 345(13), 2001, pp. 996-996
Authors:
Vonlanthen, S
Heighway, J
Altermatt, HJ
Gugger, M
Kappeler, A
Borner, MM
van Lohuizen, M
Betticher, DC
Citation: S. Vonlanthen et al., The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression, BR J CANC, 84(10), 2001, pp. 1372-1376
Authors:
Pirnia, F
Breuleux, M
Schneider, E
Hochmeister, M
Bates, SE
Marti, A
Hotz, MA
Betticher, DC
Borner, MM
Citation: F. Pirnia et al., Uncertain identity of doxorubicin-resistant MCF-7 cell lines expressing mutated p53, J NAT CANC, 92(18), 2000, pp. 1535-1536
Authors:
Pabst, T
Peters, UR
Tinguely, M
Schwaller, J
Tschan, M
Aebi, S
Vonlanthen, S
Borisch, B
Betticher, DC
Zimmermann, A
Tobler, A
Fey, MF
Citation: T. Pabst et al., Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14(ARF) /p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemia, LEUK LYMPH, 37(5-6), 2000, pp. 639-648
Authors:
Vonlanthen, S
Heighway, J
Kappeler, A
Altermatt, HJ
Borner, MM
Betticher, DC
Citation: S. Vonlanthen et al., p21 is associated with cyclin D1, p16INK4a and pRb expression in resectable non-small cell lung cancer, INT J ONCOL, 16(5), 2000, pp. 951-957
Authors:
Ghielmini, M
Schmitz, SFH
Burki, K
Pichert, G
Betticher, DC
Stupp, R
Wernli, M
Lohri, A
Schmitter, D
Bertoni, F
Cerny, T
Citation: M. Ghielmini et al., The effect of Rituximab on patients with follicular and mantle-cell lymphoma, ANN ONCOL, 11, 2000, pp. 123-126
Authors:
Sonderegger, T
Betticher, DC
Cerny, T
Lauterburg, BH
Citation: T. Sonderegger et al., Pharmacokinetics of 2-chloro-2 '-deoxyadenosine administered subcutaneously or by continuous intravenous infusion, CANC CHEMOT, 46(1), 2000, pp. 40-42
Authors:
Calderoni, A
Cerny, T
Betticher, DC
Citation: A. Calderoni et al., Is chemotherapy of small cell lung cancer progressing?, SCHW MED WO, 129(37), 1999, pp. 1313-1320
Authors:
Tschan, MP
Peters, UR
Cajot, JF
Betticher, DC
Fey, MF
Tobler, A
Citation: Mp. Tschan et al., The cyclin-dependent kinase inhibitors p18(INK4c) and p19(INK4d) are highly expressed in CD34(+) progenitor and acute myeloid leukaemic cells but notin normal differentiated myeloid cells, BR J HAEM, 106(3), 1999, pp. 644-651
Authors:
Laurencet, FM
Zulian, GB
Guetty-Alberto, M
Iten, PA
Betticher, DC
Alberto, P
Citation: Fm. Laurencet et al., Cladribine with cyclophosphamide and prednisone in the management of low-grade lymphoproliferative malignancies, BR J CANC, 79(7-8), 1999, pp. 1215-1219
Authors:
Borner, MM
Brousset, P
Pfanner-Meyer, B
Bacchi, M
Vonlanthen, S
Hotz, MA
Altermatt, HJ
Schlaifer, D
Reed, JC
Betticher, DC
Citation: Mm. Borner et al., Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 inprimary resected non-small cell lung cancer, BR J CANC, 79(5-6), 1999, pp. 952-958
Risultati:
1-13
|